Subtype-Independent Activation of NF-κB Signaling in Breast Cancer
International Journal of Molecular Sciences · 30.04.2026 · 27 (9) · 4055
DOI: 10.3390/ijms27094055 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.04.2026. Verfasst von Elżbieta Mitka-Krysiak und 13 weiteren Autor:innen. Beteiligte Einrichtung: Collegium Medicum, WSB University, 41-300 Dabrowa Gornicza, Poland. Hauptthemen laut MEDLINE: Breast Neoplasms, NF-kappa B, Signal Transduction. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nuclear factor kappa B (NF-κB) signaling plays a central role in inflammation, immunity, cell survival, and cancer progression. Its constitutive activation is frequently observed in breast cancer, contributing to tumor growth, treatment resistance, and metastasis. MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression and may modulate NF-κB signaling in a subtype-specific or -independent manner. The aim of the study was to identify miRNAs that may potentially regulate the activity of genes associated with NF-κB signaling across five molecular subtypes of breast cancer in Polish women. Tumor and matched normal tissue samples were collected from 405 patients with five breast cancer subtypes: luminal A (n = 130), HER2-negative luminal B (n = 100), HER2-positive luminal B (n = 96), non-luminal HER2-positive (n = 36), and triple-negative breast cancer (TNBC, n = 43). Expression profile of selected NF-κB-related genes were evaluated using mRNA microarrays and RT-qPCR. Protein levels were assessed by ELISA. Candidate regulatory miRNAs were identified via miRNA microarrays and validated using the miRDB database. A consistent upregulation of MAP3K7, TAB2, TNFAIP3, CSNK2A1, BCL2L1, XIAP, CXCL2, and PLAU was observed across all subtypes, suggesting activation of canonical NF-κB signaling. Downregulation of specific miRNAs, miR-1297 and miR-30a (targeting MAP3K7), miR-134 (TAB2), miR-125b (TNFAIP3), and miR-4329 (XIAP), may contribute to this deregulation. For CSNK2A1, BCL2L1, CXCL2, and PLAU, no regulatory miRNAs meeting our criteria were identified. Our study reveals a subtype-independent activation of the canonical NF-κB signaling pathway in breast cancer, underpinned by consistent upregulation of key components (at both the transcript and protein levels. Dysregulation of specific miRNAs likely contributes to this altered gene expression. These findings suggest the presence of a common NF-κB-driven oncogenic program across molecular subtypes, with potential implications for developing miRNA-based therapeutic strategies targeting inflammation, survival signaling, and treatment resistance in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collegium Medicum, WSB University, 41-300 Dabrowa Gornicza, Poland.
- Department of Mother and Child Health, Faculty of Health Sciences, Institute of Nursing and Midwifery, Jagiellonian University Medical College, 31-008 Kraków, Poland.
- Department of Plastic Surgery, Faculty of Medicine, Academia of Silesia, 40-555 Katowice, Poland.
- Department of Plastic and Reconstructive Surgery, Hospital for Minimally Invasive and Reconstructive Surgery in Bielsko-Biała, 43-316 Bielsko-Biala, Poland.
- Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University in Kraków, 30-705 Kraków, Poland.
- Department of Gynecology and Obstetrics, TOMMED Specjalisci od Zdrowia, 40-055 Katowice, Poland.
ORCID-Profile: Nikola Zmarzły, Dariusz Boroń, Beniamin Oskar Grabarek
Zitieren
APA
Mitka-Krysiak, E., Król-Jatręga, K., Ossowski, P., Zmarzły, N., Bereza, K., Ordon, P., Sirek, T., Sirek, A., Boroń, K., Boroń, D., Wyrobiec, G., Szczepanik, T., Skorek, M., & Grabarek, B. O. (2026). Subtype-Independent Activation of NF-κB Signaling in Breast Cancer. International Journal of Molecular Sciences, 27(9), 4055. https://doi.org/10.3390/ijms27094055
Vancouver
Mitka-Krysiak E, Król-Jatręga K, Ossowski P, Zmarzły N, Bereza K, Ordon P, et al. Subtype-Independent Activation of NF-κB Signaling in Breast Cancer. International Journal of Molecular Sciences. 2026;27(9):4055. doi:10.3390/ijms27094055
BibTeX
@article{MitkaKrysiak2026,
author = {Mitka-Krysiak, Elżbieta and Król-Jatręga, Katarzyna and Ossowski, Piotr and Zmarzły, Nikola and Bereza, Krzysztof and Ordon, Paweł and Sirek, Tomasz and Sirek, Agata and Boroń, Kacper and Boroń, Dariusz and Wyrobiec, Grzegorz and Szczepanik, Tomasz and Skorek, Marta and Grabarek, Beniamin Oskar},
title = {Subtype-Independent Activation of NF-κB Signaling in Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {9},
pages = {4055},
doi = {10.3390/ijms27094055}
}
EUVIMED